unknown
Stage
About
FibroGen (now rebranded as Kyntra Bio) is a biopharmaceutical company focused on developing therapies for serious and life-threatening diseases, including anemia and oncology.
Explore FibroGen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.